Annex
United Kingdom
Annex XVII to Regulation (EC) No 1907/2006 is amended as follows:
- (1)
Column 1 of entries 28 to 30 is replaced by the following:
‘
28. Substances which are classified as carcinogen category 1A or 1B in Part 3 of Annex VI to Regulation (EC) No 1272/2008 and are listed in Appendix 1 or Appendix 2, respectively. 29. Substances which are classified as germ cell mutagen category 1A or 1B in Part 3 of Annex VI to Regulation (EC) No 1272/2008 and are listed in Appendix 3 or Appendix 4, respectively. 30. Substances which are classified as reproductive toxicant category 1A or 1B in Part 3 of Annex VI to Regulation (EC) No 1272/2008 and are listed in Appendix 5 or Appendix 6, respectively. ’
- (2)
In Appendix 2, the following entries are inserted in the table in order of the index numbers set out therein:
‘
2,3-epoxypropyl methacrylate;
glycidyl methacrylate
607-123-00-4 203-441-9 106-91-2 cadmium carbonate 048-012-00-5 208-168-9 513-78-0 cadmium hydroxide; cadmium dihydroxide 048-013-00-0 244-168-5 21041-95-2 cadmium nitrate; cadmium dinitrate 048-014-00-6 233-710-6 10325-94-7 formaldehyde … % 605-001-00-5 200-001-8 50-00-0 anthraquinone 606-151-00-4 201-549-0 84-65-1 N,N′-methylenedimorpholine;
N,N′-methylenebismorpholine;
[formaldehyde released from N,N′-methylenebismorpholine];
[MBM]
607-721-00-5 227-062-3 5625-90-1 reaction products of paraformaldehyde and 2-hydroxypropylamine (ratio 3:2);
[formaldehyde released from 3,3′-methylenebis[5-methyloxazolidine];
formaldehyde released from oxazolidin];
[MBO]
612-290-00-1 — — reaction products of paraformaldehyde with 2-hydroxypropylamine (ratio 1:1);
[formaldehyde released from α,α,α-trimethyl-1,3,5-triazine-1,3,5(2H,4H,6H)-triethanol];
[HPT]
612-291-00-7 — — methylhydrazine 612-292-00-2 200-471-4 60-34-4 ’
- (3)
In Appendix 4, the following entries are inserted in the table in order of the index numbers set out therein:
‘
cadmium carbonate 048-012-00-5 208-168-9 513-78-0 cadmium hydroxide; cadmium dihydroxide 048-013-00-0 244-168-5 21041-95-2 cadmium nitrate; cadmium dinitrate 048-014-00-6 233-710-6 10325-94-7 ’
- (4)
In Appendix 6, the following entries are inserted in the table in order of the index numbers set out therein:
‘
2-methyl-1-(4-methylthiophenyl)-2-morpholinopropan-1-one 606-041-00-6 400-600-6 71868-10-5 2,3-epoxypropyl methacrylate;
glycidyl methacrylate
607-123-00-4 203-441-9 106-91-2 cyproconazole (ISO); (2RS,3RS;2RS,3SR)-2-(4-chlorophenyl)-3-cyclopropyl-1-(1H-1,2,4-triazol-1-yl)butan-2-ol 650-032-00-X — 94361-06-5 dibutyltin dilaurate; dibutyl[bis(dodecanoyloxy)]stannane 050-030-00-3 201-039-8 77-58-7 nonadecafluorodecanoic acid; [1]
ammonium nonadecafluorodecanoate; [2]
sodium nonadecafluorodecanoate [3]
607-720-00-X 206-400-3 [1]
221-470-5 [2]
[3]
335-76-2 [1]
3108-42-7 [2]
3830-45-3 [3]
triadimenol (ISO); (1RS,2RS;1RS,2SR)-1-(4-chlorophenoxy)-3,3-dimethyl-1-(1H-1,2,4-triazol-1-yl)butan-2-ol;
α-tert-butyl-β-(4-chlorophenoxy)-1H-1,2,4-triazole-1-ethanol
613-322-00-7 259-537-6 55219-65-3 quinolin-8-ol;
8-hydroxyquinoline
613-324-00-8 205-711-1 148-24-3 thiacloprid (ISO);
(Z)-3-(6-chloro-3-pyridylmethyl)-1,3-thiazolidin-2-ylidenecyanamide;
{(2Z)-3-[(6-chloropyridin-3-yl)methyl]-1,3-thiazolidin-2-ylidene}cyanamide
613-325-00-3 — 111988-49-9 carbetamide (ISO);
(R)-1-(ethylcarbamoyl)ethyl carbanilate; (2R)-1-(ethylamino)-1-oxopropan-2-yl phenylcarbamate
616-223-00-7 240-286-6 16118-49-3 ’